Paper42972020PubMed
Predicting responses to prebiotic fibres: linking microbiota, function and clinical outcomes.
Cantu-Jungles T and 9 others. Nat Rev Microbiol, 2026.
Cite this record
ConductScience Library. Predicting responses to prebiotic fibres: linking microbiota, function and clinical outcomes. Papers, record 42972020. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42972020
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predicting responses to prebiotic fibres: linking microbiota, function and clinical outcomes.
- Journal
- Nat Rev Microbiol
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-11-02
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References148
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28611480 | Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28611480 | PubMed |
| 2 | 24226770 | Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. | Nature | 2013 | https://conductscience.org/library/papers/24226770 | PubMed |
| 3 | 23652017 | The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. | Nat Commun | 2013 | https://conductscience.org/library/papers/23652017 | PubMed |
| 4 | 24412651 | Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. | Cell | 2014 | https://conductscience.org/library/papers/24412651 | PubMed |
| 5 | 27863247 | A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. | Cell | 2016 | https://conductscience.org/library/papers/27863247 | PubMed |
| 6 | 32199523 | Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women. | J Acad Nutr Diet | 2020 | https://conductscience.org/library/papers/32199523 | PubMed |
| 7 | 29307330 | Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study. | Br J Nutr | 2018 | https://conductscience.org/library/papers/29307330 | PubMed |
| 8 | 35902900 | Microbiota responses to different prebiotics are conserved within individuals and associated with habitual fiber intake. | Microbiome | 2022 | https://conductscience.org/library/papers/35902900 | PubMed |
| 9 | 26552345 | Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella. | Cell Metab | 2015 | https://conductscience.org/library/papers/26552345 | PubMed |
| 10 | 36446139 | Predicting Personalized Responses to Dietary Fiber Interventions: Opportunities for Modulation of the Gut Microbiome to Improve Health. | Annu Rev Food Sci Technol | 2023 | https://conductscience.org/library/papers/36446139 | PubMed |
| 11 | 35776947 | Perspective: Leveraging the Gut Microbiota to Predict Personalized Responses to Dietary, Prebiotic, and Probiotic Interventions. | Adv Nutr | 2022 | https://conductscience.org/library/papers/35776947 | PubMed |
| 12 | 38110694 | Utilization of the microbiome in personalized medicine. | Nat Rev Microbiol | 2024 | https://conductscience.org/library/papers/38110694 | PubMed |
| 13 | 34016169 | Gut microbiome variation modulates the effects of dietary fiber on host metabolism. | Microbiome | 2021 | https://conductscience.org/library/papers/34016169 | PubMed |
| 14 | 36707729 | Pharmacogenomics: current status and future perspectives. | Nat Rev Genet | 2023 | https://conductscience.org/library/papers/36707729 | PubMed |
| 15 | 11325631 | Clinical application of pharmacogenetics. | Trends Mol Med | 2001 | https://conductscience.org/library/papers/11325631 | PubMed |
| 16 | 25925459 | Personalized medicine: Time for one-person trials. | Nature | 2015 | https://conductscience.org/library/papers/25925459 | PubMed |
| 17 | 31884147 | Treating treatment non-responders: A meta-analysis of randomized controlled psychotherapy trials. | Clin Psychol Rev | 2020 | https://conductscience.org/library/papers/31884147 | PubMed |
| 18 | 32171307 | Treating non-responders: pitfalls and implications for cancer immunotherapy trial design. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32171307 | PubMed |
| 19 | 25156449 | Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. | Cell Metab | 2014 | https://conductscience.org/library/papers/25156449 | PubMed |
| 20 | 2181501 | Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. | Physiol Rev | 1990 | https://conductscience.org/library/papers/2181501 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42972020
GET https://conductscience.org/api/papers/v1/42972020/references?page=2